• CAPRI Management Committee
  • CAPRI Evaluation Team
  • CAPRI Former Management Committee Members
  • Structural Biologists who contributed to CAPRI

    CAPRI Management Committee Members

    CAPRI Evaluation Team

    CAPRI Former Management Committee Members

    Structural Biologists who contributed to CAPRI

    • C. Arrowsmith (Structural Genomics Consortium, University of Toronto, Canada)

    • D. Baker (University of Washington Seattle, WA, USA)

    • R. Bao (University of Science and Technology of China, Hefei, China)

    • A. Basle (Newcastle University, UK)

    • M. Buck (Case Western Reserve University, Cleveland, USA)

    • C.-W. Chang and B. Kobe (University of Queensland, Brisbane, Australia)

    • Y. Chen (University of Science and Technology of China, Hefei, China)

    • I. Gutsche (Institut de Biologie Structurale, Grenoble, France)

    • C. Kleanthous (Oxford University, UK)

    • R. Efremov (VIB-VUB, Brussels, Belgium;)

    • A. Fioravanti (VIB-VUB Center for Structural Biology, Brussels, Belgium;)

    • S. Fleishman (Weizmann Institute, Israel)

    • C. Fontes (University of Lisbon, Portugal)

    • B. Fox (University of Wisconsin, Madison, Wisconsin, USA)

    • G. Garcia-Rodriguez (VIB-VUB, Brussels, Belgium)

    • M. Graille (Université Paris-Sud, Orsay, France)

    • Wi Huang (Case Western Reserve University, USA)

    • J. Hurley (UC Berkeley, USA)

    • B Janssen (Utrecht University, The Netherlands)

    • J. L. Keck (University of Wisconsin, Madison, USA)

    • C. Kleanthous (University of York, UK)

    • P. Kursula (University of Bergen, Norway)

    • S. Lansky (Hebrew University of Jerusalem, Israel)

    • N. Leulliot (Université Paris-Sud, Orsay, France)

    • R. Lewis (Newcastle University, UK)

    • S. Leysen (Catholic University Leuven, Belgium)

    • R. Loris (VIB-VUB, Brussels, Belgium)

    • L. de Maria (Novozymes, Bagsvaerd, Denmark)

    • R. McGuinty (Penn State University, USA)

    • J. Marquez (EMBL Grenoble, France)

    • N. Meenan (University of York, United Kingdom)

    • J. Ménétrey (Institut Curie, Paris, France)

    • P. Minard (Université Paris-Sud, Orsay, France)

    • R. Moretti (University of Washington Seattle, WA, USA)

    • S. Najmudin (University of Lisbon, Portugal)

    • Ravit Netzer (Weizmann Institute, Israel)

    • T. K. Nielsen (Max Planck Institut, Göttingen, Germany)

    • H. Park (Structural Genomics Consortium, University of Toronto, Canada)

    • M. Pronker (Utrecht University, The Netherlands)

    • H. Remaut (VIB-VUB Center for Structural Biology, Brussels, Belgium;)

    • L. Renault (LEBS-CNRS, Gif-sur-Yvette, France)

    • A. Roussel (Université Aix Marseille, France)

    • P. Rucktooa (University of Lille, France)

    • S. Savvides ()

    • G. Shoham (Hebrew University of Jerusalem, Israel)

    • T. Sixma (Netherlands Cancer Institute, Amsterdam, the Netherlands)

    • R. Sprangers (Max Planck Institute for Developmental Biology, Tübingen, Germany)

    • Strelkov (Catholic University Leuven, Belgium)

    • S. Tan (Penn State University, USA)

    • W. Tempel (Structural Genomics Consortium, University of Toronto, Canada)

    • H. van Tilbeurgh (Université Paris-Sud, Orsay, France)

    • Y. Tong (Structural Genomics Consortium, University of Toronto, Canada)

    • O. Vaněk (Charles University, Prague, Czech Republic)

    • A. Vangone (Roche, Germany)

    • V. Villeret and Philippe Delepelaire (Universities of Lille and Paris-7, France)

    • J. Walker (Structural Genomics Consortium, Toronto, Canada)

    • T. Whitehead (University of Washington Seattle, WA, USA)

    • J.A. Wojdyla (University of York, UK)